ProQR Therapeutics
PRQR
PRQR
62 hedge funds and large institutions have $82.4M invested in ProQR Therapeutics in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 21 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
62
Holders Change
-2
Holders Change %
-3.13%
% of All Funds
0.83%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
4
Increased
16
Reduced
21
Closed
6
Calls
$150K
Puts
$20K
Net Calls
+$130K
Net Calls Change
+$97K
Top Buyers
| 1 |
Morgan Stanley
New York
|
$6.29M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
$1.77M |
| 3 |
AAA
Affinity Asset Advisors
New York
|
$7.14M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
$3.07M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$229K |
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
$13.5M |
| 2 |
Millennium Management
New York
|
$2.67M |
| 3 |
UBS Group
Zurich,
Switzerland
|
$2.33M |
| 4 |
Citadel Advisors
Miami,
Florida
|
$774K |
| 5 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
$3.36M |
